Business Description
Acutaas Chemicals Ltd
ISIN : INE00FF01025
Total Employee Number:
1,465Compare
Compare
Traded in other countries / regions
543349.India Index Membership
NIFTY 500 IPO Date
2021-09-14Description
Acutaas Chemicals Ltd is principally engaged in the business of drugs intermediate chemicals and related activities. It manufactures different types of pharmaceutical intermediates and active pharmaceutical ingredients, specialty chemicals, and formulations. Its products are used in various industrial sectors, including Pharmaceutical, Personal Care, Cosmetics, Dyes, Polymers, Agro Chemicals, and Animal Foods industries. The company caters to both domestic and international markets and generates the majority of its revenue from outside India.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 28.82 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.02 | |||||
Interest Coverage | 129.84 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 72.52 | |||||
Beneish M-Score | -2.03 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 18 | |||||
3-Year EBITDA Growth Rate | 25.4 | |||||
3-Year EPS without NRI Growth Rate | 23.5 | |||||
3-Year FCF Growth Rate | -12.6 | |||||
3-Year Book Growth Rate | 30.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 50.22 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 31.29 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 88.56 | |||||
9-Day RSI | 81.55 | |||||
14-Day RSI | 76.54 | |||||
3-1 Month Momentum % | 48.6 | |||||
6-1 Month Momentum % | 79.25 | |||||
12-1 Month Momentum % | 184.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.6 | |||||
Quick Ratio | 2.73 | |||||
Cash Ratio | 1.1 | |||||
Days Inventory | 106.18 | |||||
Days Sales Outstanding | 82.95 | |||||
Days Payable | 91.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.04 | |||||
Dividend Payout Ratio | 0.04 | |||||
Forward Dividend Yield % | 0.04 | |||||
5-Year Yield-on-Cost % | 0.04 | |||||
3-Year Average Share Buyback Ratio | -4 | |||||
Shareholder Yield % | 0.37 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 49.88 | |||||
Operating Margin % | 28.82 | |||||
Net Margin % | 23.72 | |||||
EBITDA Margin % | 34.61 | |||||
FCF Margin % | -6.32 | |||||
OCF Margin % | 9.8 | |||||
ROE % | 21.9 | |||||
ROA % | 18.4 | |||||
ROIC % | 22.7 | |||||
3-Year ROIIC % | 11.82 | |||||
ROC (Joel Greenblatt) % | 38.92 | |||||
ROCE % | 28.45 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 105.63 | |||||
Forward PE Ratio | 68.69 | |||||
PE Ratio without NRI | 105.63 | |||||
PEG Ratio | 3.58 | |||||
PS Ratio | 25.18 | |||||
PB Ratio | 21.37 | |||||
Price-to-Tangible-Book | 22.67 | |||||
Price-to-Operating-Cash-Flow | 249.87 | |||||
EV-to-EBIT | 78.06 | |||||
EV-to-EBITDA | 71.77 | |||||
EV-to-Forward-EBITDA | 37.87 | |||||
EV-to-Revenue | 24.84 | |||||
EV-to-Forward-Revenue | 8.05 | |||||
EV-to-FCF | -393.3 | |||||
Price-to-GF-Value | 2.82 | |||||
Price-to-Peter-Lynch-Fair-Value | 4.23 | |||||
Price-to-Graham-Number | 11.62 | |||||
| Price-to-Net-Current-Asset-Value | 59.5 | |||||
Earnings Yield (Greenblatt) % | 1.28 | |||||
FCF Yield % | -0.25 | |||||
Forward Rate of Return (Yacktman) % | 19.75 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Acutaas Chemicals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 12,081.91 | ||
| EPS (TTM) (₹) | 34.94 | ||
| Beta | -0.4394 | ||
| 3-Year Sharpe Ratio | 1.55 | ||
| 3-Year Sortino Ratio | 4.11 | ||
| Volatility % | 38.37 | ||
| 14-Day RSI | 76.54 | ||
| 14-Day ATR (₹) | 126.143733 | ||
| 20-Day SMA (₹) | 3295.74 | ||
| 12-1 Month Momentum % | 184.88 | ||
| 52-Week Range (₹) | 1094.9 - 3730.9 | ||
| Shares Outstanding (Mil) | 81.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Acutaas Chemicals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Acutaas Chemicals Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2026-10-16 15:30 | In 104 days | ||
| Second quarter earnings results for 2027 | 2026-10-16 | In 103 days | ||
| General meeting for 2026 | 2026-09-25 11:30 | In 83 days | ||
| Annual report for 2026 | 2026-09-01 | In 58 days | ||
| First quarter earnings conference call for 2027 | 2026-07-30 16:30 | In 26 days | ||
| First quarter earnings results for 2027 | 2026-07-30 | In 25 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-04-30 17:30 | 2,502.40 (+0.90%) | ||
| Fourth quarter earnings results for 2026 | 2026-04-30 | 2,502.40 (+0.90%) | ||
| Third quarter earnings conference call for 2026 | 2026-01-28 17:00 | 1,728.00 (+4.10%) | ||
| Third quarter earnings results for 2026 | 2026-01-28 | 1,728.00 (+4.10%) |
Show
Entries
Acutaas Chemicals Ltd Frequently Asked Questions
What is Acutaas Chemicals Ltd(NSE:ACUTAAS)'s stock price today?
The current price of NSE:ACUTAAS is ₹3694.80. The 52 week high of NSE:ACUTAAS is ₹3730.90 and 52 week low is ₹1094.90.
When is next earnings date of Acutaas Chemicals Ltd(NSE:ACUTAAS)?
The next earnings date of Acutaas Chemicals Ltd(NSE:ACUTAAS) is 2026-07-30 Est..
Does Acutaas Chemicals Ltd(NSE:ACUTAAS) pay dividends? If so, how much?
The Dividend Yield %  of Acutaas Chemicals Ltd(NSE:ACUTAAS) is 0.04% (As of Today), Highest Dividend Payout Ratio of Acutaas Chemicals Ltd(NSE:ACUTAAS) was 0.17. The lowest was 0.04. And the median was 0.13. The  Forward Dividend Yield % of Acutaas Chemicals Ltd(NSE:ACUTAAS) is 0.04%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Acutaas Chemicals Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers